Bárbara de Azevedo Abrahim Vieira
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Farmácia
Departamento:
Departamento de Fármacos e Medicamentos
e-mail:
barbaraabrahim@pharma.ufrj.br
Linkedin:
Google Scholar:
ORCID:
não disponível no Lattes
Formação:
-
Rice University
| Pós-Doutorado | 2023 - 2024
-
Universidade Federal do Rio de Janeiro
| Pós-Doutorado | 2014 - 2015
-
Universidade Federal do Rio de Janeiro
Ciências Farmacêuticas | Doutorado | 2011 - 2013
-
Universidade Federal Fluminense
Ciências Aplicadas a Produtos Para Saúde | Mestrado | 2009 - 2011
-
Universidade Federal Fluminense
Farmácia Industrial | Graduação | 2002 - 2008
-
Escola Técnica Federal de Química
Técnico em Química | Ensino Profissional de nível técnico | 1998 - 2000
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(94.29% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| 4-oxoquinoline-3-carboxamide acyclonucleoside phosphonates hybrids: Human MCF-7 breast cancer cell death induction by oxidative stress-promoting and in silico ADMET studies | 10.1016/j.molstruc.2022.134542 | 2023 |
| In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein | 10.3390/ pharmaceutics15041095 | 2023 |
| Physiologically-based pharmacokinetics modeling of Semaglutide in children and adolescents with healthy and obese body weights | 10.1111/bcp.15816 | 2023 |
| Myeloperoxidase Inhibitors as Anti-Inflammatory Drug Candidates | 10.21577/1984-6835.20220022 | 2022 |
| In silico analyzes of acetylcholinesterase (AChE) and its genetic variants in interaction with the anti-Alzheimer drug Rivastigmine | 10.1002/jcb.30277 | 2022 |
| Evaluation of biological activities of quinone-4-oxoquinoline derivatives against pathogens of clinical importance | 10.2174/1568026622666220504124710 | 2022 |
| Alternative Methods for Pulmonary-Administered Drugs Metabolism: a Breath of Change | 10.2174/1389557522666220620125623 | 2022 |
| Toxicological assessment of SGLT2 inhibitors metabolites using in silico approach | 10.1590/0001-3765202220211287 | 2022 |
| Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis | 10.1371/journal.pone.0247841 | 2021 |
| Chalcones identify cTXNPx as a potential antileishmanial drug target | 10.1371/journal.pntd.0009951 | 2021 |
| Evaluation of chloroquine and hydroxychloroquine as ACE-2 Inhibitors By In Silico Approaches: Cardiac Arrhythmia Cause? | 10.1016/j.molstruc.2021.130946 | 2021 |
| Forced Degradation Studies of Norepinephrine and Epinephrine from dental anesthetics: Development of Stability-Indicating HPLC Method and In Silico Toxicity evaluation | 10.1002/bmc.4832 | 2020 |
| Synthesis, In Vitro and In Silico Studies of Indolequinone Derivatives against Clinically Relevant Bacterial Pathogens | 10.2174/1568026620666191223110518 | 2020 |
| In Silico studies of novel Sildenafil self-emulsifying drug delivery system absorption improvement for pulmonary arterial hypertension | 10.1590/0001-3765202020191445 | 2020 |
| Structure-activity relationship, molecular docking, and molecular dynamic studies of diterpenes from marine natural products with anti-HIV activity | 10.1080/07391102.2020.1845977 | 2020 |
| Trehalose synthesis inhibitor: A molecular in silico drug design | 10.1002/jcb.29347 | 2019 |
| A comprehensive review of chalcone derivatives as antileishmanial agents | 10.1016/j.ejmech.2018.03.047 | 2018 |
| Fitoterápicos: uma possibilidade na clínica odontopediátrica | 10.26843/ro_unicidv3012018p77-82 | 2018 |
| Brazilian stingless bee propolis and geopropolis: promising sources of biologically active compounds | 10.1016/j.bjp.2018.11.007 | 2018 |
| Insights into cytochrome bc1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling | 2017 | |
| Identification, characterization and in silico ADMET prediction of Roflumilast degradation products | 10.1016/j.jpba.2017.02.012 | 2017 |
| Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor | 10.1016/j.bmcl.2016.11.051 | 2017 |
| Preparation methods and applications behind alginate-based particles | 10.1080/17425247.2016.1214564 | 2016 |
| Sodium Montmorillonite/Amine-Containing Drugs Complexes: New Insights on Intercalated Drugs Arrangement into Layered Carrier Material | 10.1371/journal.pone.0121110 | 2015 |
| Antimycobacterial and Anti-Inflammatory Activities of Substituted Chalcones Focusing on an Anti-Tuberculosis Dual Treatment Approach | 10.3390/molecules20058072 | 2015 |
| Computational Studies of Benzoxazinone Derivatives as Antiviral Agents against Herpes Virus Type 1 Protease | 10.3390/molecules200610689 | 2015 |
| Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation | 10.2147/ijn.s86313 | 2015 |
| Intestinal absorption of insulin nanoparticles: contribution of M cells | 10.1016/j.nano.2014.02.014 | 2014 |
| Synthesis, Cytotoxicity and Mechanistic Evaluation of 4-Oxoquinoline-3-carboxamide Derivatives: Finding New Potential Anticancer Drugs | 10.3390/molecules19056651 | 2014 |
| Novel isomannide-based peptide mimetics containing a tartaric acid backbone as serine protease inhibitors | 10.1007/s00044-014-1058-1 | 2014 |
| Intestinal Uptake of Insulin Nanoparticles: Facts or Myths? | 10.2174/1389201015666140915151319 | 2014 |
| Segregated Delivery of Rifampicin and Isoniazid from Fixed Dose Combination Bilayer Tablets for the Treatment of Tuberculosis | 10.9734/bjpr/2014/11525 | 2014 |
| Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia | 10.1002/jps.23715 | 2013 |
| Alginate-Based Micro and Nanoparticles Coated with Chitosan | 10.1166/jcc.2013.1025 | 2013 |
| Isomannide and Derivatives. Chemical and Pharmaceutical Applications | 2010 |
Eventos:
(0.00% eventos com DOI)